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ABSTRACT
When diabetes progresses, many patients suffer from chronic foot ulcers. In a
study described in Matrix Metalloproteinases and Diabetic Foot Ulcers (Muller et al.,
2008), sixteen patients with diabetic foot ulcers were examined throughout a twelve week
healing period. During this period, levels of matrix metalloproteinases (MMP-1), their
inhibitors (TIMP-1), and the extracellular matrix in a wound area were measured at
distinct time intervals for each patient. The ratios of these healing components are vital in
determining whether a wound will heal or become chronic and never properly heal.
Connecting Local and Global Sensitivities in a Mathematical Model for Wound Healing
(Krishna et al., 2015) mathematically describes the healing interactions between the
MMP-1, TIMP-1, the extracellular matrix, and fibroblasts to highlight key differences
between those patients categorized as ‘good’ healers or as ‘poor’ healers in the Matrix
Metalloproteinases and Diabetic Foot Ulcers (Muller et al., 2008) study.
The goal of this research is to utilize the individual patient data obtained from
Matrix Metalloproteinases and Diabetic Foot Ulcers (Muller et al., 2008) to identify key
parameters, through the use of nonlinear mixed effects modeling, a technique that allows
for each parameter estimate to be split into a fixed and random effect. The fixed effect is
assumed to remain the same across every data collection. Random effects vary from
collection to collection and patient to patient. Through this split, information from the
population trends, using the fixed effect estimates, can be utilized to help inform the
individual patient estimates for patients with fewer data points. The identification of key
parameters in the healing process can provide valuable insight about which parameters
should be taken into special consideration during the diagnosis and treatment process.
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INTRODUCTION
The wound-healing process is often categorized into four stages: coagulation and
hemostasis, inflammation, proliferation, and wound remodeling (Velnar et al., 2009). The
coagulation and hemostasis phase occurs immediately after an injury is sustained in order
to stop blood loss. During this phase, a matrix is created which will allow cells needed later
in the healing process access to the wound area. There is a complex balance between
endothelial cells, thrombocytes, coagulation, and fibrinolysis that dictates hemostasis and
the overall timeline of the healing process. Due to the body’s reflex mechanisms, “injured
vessels constrict rapidly due to contraction of vascular smooth muscle cells in the circular
muscle layer” (Velnar et al., 2009). Unfortunately, this contraction only lasts for a few
minutes before hypoxia and acidosis cause the wound wall and surrounding vessels to relax
allowing bleeding to resume. Thankfully, hemostasis deposits enough fibrin at the wound
site that an insoluble fibrin plug develops to stop the bleeding. During coagulation, platelet
aggregation and clot formation occur to limit blood loss. Clots form due to complex
interactions between platelets and exposed collagen or other parts of the extracellular
matrix. These clots are composed of fibronectin, fibrin, vitronectin, and thrombospondin.
The cytoplasm of the platelets trapped in the blood clots contain various growth factors,
such as platelet derived growth factor (PDGF), transforming growth factor-β (TGF-β), and
epidermal growth factor, that activate and attract neutrophils, macrophages, endothelial
cells, and fibroblasts, important components of the future healing stages.
After the coagulation and hemostasis stage, the humoral and cellular inflammatory
phase is next, “with the aim of establishing an immune barrier against invading microorganisms” (Velnar et al., 2009). This phase is often split into an early and late
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inflammatory stage. Early inflammatory response begins during the last part of
coagulation. During this phase, the neutrophils that were previously attracted to the wound
site by the growth factors start phagocytosis, a process that destroys and removes bacteria,
foreign particles, and damaged tissue by releasing proteolytic enzymes and oxygen-derived
free radical species. “Phagocytic activity is crucial for the subsequent processes, because
acute wounds that have a bacterial imbalance will not heal” (Velnar et al., 2009). The
attraction of neutrophils occurs within 24-36 hours of injury. However after their job is
complete and all the bacteria has been removed, neutrophils are destroyed and their
remnants are phagocytosed by macrophages in the next step. Then, the late inflammatory
phase occurs between 48-72 hours after injury. This is when blood monocytes go through
phenotypic changes to become tissue macrophages. These cells “have a longer lifespan
than neutrophils and continue to work at a lower pH” (Velnar et al., 2009). The tissue
macrophages regulate the inflammatory stage and provide various tissue growth factors to
the wound site allowing healthy tissue to grow and heal the injury. A lack of monocytes or
macrophages at the wound causes serious delays in wound healing because of “poor wound
debridement, delayed fibroblast proliferation and maturation, as well as delayed
angiogenesis” (Velnar et al., 2009). Towards the end of the late inflammatory stage
lymphocytes, key factors in the development of a strong immune system, are attracted to
the wound area around 72 hours after injury by interleukin-1 (IL-1), which are important
components of collagen remodeling and the production and repair of the extracellular
matrix.
The next stage of the wound healing-process is the proliferative phase. This is the
stage where most of the tissue repair occurs. The proliferation stage generally lasts for
2

about 2 weeks after injury. This intricate stage encompasses multiple processes: fibroblast
migration, collagen synthesis, angiogenesis and granulation tissue formation, protrusion,
adhesion, and traction. Fibroblast migration typically occurs within the first 3 days of the
proliferative phase. Fibroblasts flood the wound site as they are attracted by TGF-β and
PDGF in order to produce the matrix proteins hyaluronan, fibronectin, proteoglycans, and
type-1 and type-3 procollagen and deposit them in the local milieu (Velnar et al., 2009).
After one week, fibroblasts have generated enough extracellular matrix components to
promote cell migration and the repair process. Once there is enough extracellular matrix,
fibroblasts change to their myofibroblast phenotype where they attach to fibronectin and
collagen in the extracellular matrix to extend the wound edges closer together, towards a
closed wound. Afterwards, fibroblasts that have accomplished their job and are no longer
useful are flushed out of the wound through apoptosis. Then collagen synthesis occurs in
which fibroblast cells synthesize collagen such that the newly synthesized collagen can
“impart integrity and strength to all tissues” (Velnar et al., 2009) acting as a foundation for
healing. Next, angiogenesis begins to remodel old and generate new blood vessels. Since
there is no viable tissue at the wound center, all the new blood vessels are concentrated
around the wound margins. After a few days while the collagen grows toward the wound
center, new capillary networks extend toward the wound center and connect with capillary
sprouts from the edges of the wound clot. The last three parts of the proliferative phase,
protrusion, adhesion, and traction, are required to ensure cellular motility as well as
movement and migration of cells from one location to another through the combustion of
energy.
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The final stage of wound healing is the remodeling phase which is “responsible for
the development of new epithelium and final scar tissue formation” (Velnar et al., 2009).
This phase of the wound healing process can last up to two years. During the remodeling
phase of an acute wound, there are many regulatory mechanisms that maintain the strict
equilibrium between degradation and synthesis. Though the entirety of the remodeling
process may take years, the remodeling of the extracellular matrix around the wound site
becomes rather stable about three weeks after injury. Matrix metalloproteinase enzymes
breakdown collagen within the extracellular matrix that was damaged when the injury
occurred. Tissue inhibitors of metalloproteinases regulated the activity of matrix
metalloproteinases. “Gradually, the activity of tissue inhibitors of metalloproteinases
increases, culminating in a drop in activity of metalloproteinase enzymes, thereby
promoting new matrix accumulation.” (Velnar et al., 2009). In order to close the wound,
“underlying connective tissue shrinks in size and brings the wound margins closer together,
owing to fibroblast interactions with the extracellular matrix” (Velnar, 2009). As the
wound heals, fibroblasts and macrophages exit the wound area through apoptosis, the
growth of capillaries stops, and blood flow to the area declines. “The end result is a fully
matured scar with a decreased number of cells and blood vessels and a high tensile
strength” (Velnar, 2009).
Acute wounds are wounds that follow the healing process described above. Chronic
wounds do not follow this typical pattern of healing, often leading to prolonged healing
and open wounds. They have been described as “wounds that have failed to return to
functional and anatomical integrity in a timely fashion” (Telgenhoff et al., 2005). Most
chronic wounds are either pressure sores, diabetic ulcers, or venous ulcers. The fact that
4

these wounds do not follow the standard healing process typically stems from one of three
factors: the cellular and systemic effects of aging, repeated ischemia-reperfusion injury, or
bacterial contamination resulting in an inflammatory response (Telgenhoff et al., 2005).
Most chronic wounds can be healed, the process simply takes longer and more medical
attention than an acute wound. However there is an estimated 15-20% of chronic wound
patients that suffer with non-healing wounds. These wounds typically display “decreased
growth factors, decreased keratinocyte migration, increased reactive oxygen species,
increased tissue proteases, and microbial contamination” (Telgenhoff et al., 2005).
Diabetic foot ulcers are the most costly chronic wounds to care for and the most likely to
become a non-healing chronic wound, often leading to amputation (Apelquist et al., 1993).
This paper will specifically be examining diabetic foot ulcers. It was found in a
study by Lobmann, et al (2002). that when comparing diabetic chronic wounds and
nondiabetic acute wounds, the concentrations of matrix metalloproteinases were
significantly higher in diabetic foot ulcers. Specifically, the concentration of MMP-1, a
type of matrix metalloproteinases, was increased 65-fold in diabetic wounds than in acute,
traumatic wounds. Similarly, MMP-2 concentrations were increased threefold, twofold for
MMP-8 and 14-fold for MMP-9. It was also found that TIMP-2, the tissue inhibitor for
MMP-2, was reduced twofold in the diabetic ulcers. This combination of higher
concentrations of MMP’s and lower concentrations of TIMP’s means that the tissue
inhibitors are outnumbered and cannot stop the matrix metalloproteinase enzymes from
continued destruction of collagen and other parts of the extracellular matrix. Therefore new
matrix accumulation never occurs and the wound will not be able to close, leading to a
non-healing wound.
5

THE MODEL
In order to examine the healing process of chronic wounds, a model must be
instituted such that variability in the data can be attributed to specific parameters. The
model that this paper will be using is a modified version of the model that can be found in
the Krishna, et al. (2015) paper Connecting Local and Global Sensitivities in a
Mathematical Model for Wound Healing. This model uses four state variables and twelve
parameters in four differential equations to describe the wound-healing process explained
above. Specifically, the model examines concentrations of MMP-1 and TIMP-1 as well as
extracellular matrix levels and fibroblast cell counts; these are the four state variables. The
model was designed using data collected from chronic diabetic foot ulcers of sixteen type2 diabetic patients (Muller et al., 2008). MMP-1 and TIMP-1 concentrations were
measured using wound fluid collected from absorbent paper strips placed on the edge of
the wound for five minutes. Because there was a possibility of variant amounts of fluid
collected from each wound, data for MMP-1 and TIMP-1 were recorded as ratios of the
number of MMP-1 or TIMP-1 proteins to the total number of proteins collected.
Extracellular matrix (ECM) data was measured according to wound area which was
examined through numeric photography and analytical software. “ECM levels were taken
to be proportional to wound closure” (Krishna et al., 2015) such that the largest ECM value
of 1 corresponds to a fully closed wound. Though there is no data in the Muller et al. study
for the fibroblast concentrations, fibroblast cells are important to the wound-healing
process, since they are the cells that produce the proteins needed for wound healing, and
have therefore been included in the model. There were modifications made to the equations
because the original model was created using average patient data. Now that de-identified
6

individual patient data are available some changes were made to combat parameter
identifiability issues and to better represent the individual patient data. With all of these
changes, the new model is:

𝑑𝑀 𝑘1 𝑀3 (𝑓̃ + 𝑓𝑖 )
=
− 𝑘3 𝑀 − 𝑘4 𝑀𝑇
𝑑𝑡
𝑘23 + 𝑀3
𝑑𝑇 𝑘5 𝑇 3 (𝑓̃ + 𝑓𝑖 )𝑀
=
− 𝑘7 𝑇 − 𝑘4 𝑀𝑇
𝑑𝑡
𝑘63 + 𝑇 3
𝑑𝐸
= 𝑘8 (𝑓̃ + 𝑓𝑖 )(1 − 𝐸 ) − 𝑘9 𝑀𝐸 − 𝑘10 𝐸
𝑑𝑡
𝑑𝑓̃
= 𝑘11 (𝑓̃ + 𝑓𝑖 )[1 − (𝑓̃ + 𝑓𝑖 )]
𝑑𝑡
Equation 1: Mathematical model describing wound healing

The four state variables matrix metalloproteinases (MMP-1), tissue inhibitors of
matrix metalloproteinases (TIMP-1), extracellular matrix (ECM), and fibroblasts are
represented by M, T, E, and 𝑓̃, respectively. The twelve parameters are k1 through k11 and
fi, which is the initial concentration of fibroblasts.
The three main rescalings performed on the data and the model to more adequately
describe the individual patient data are updated initial TIMP-1 concentration, changed
initial condition of the ECM, and the scaling out of the death term, 𝑘12 , in the original

𝑑𝑓
= 𝑘11 𝑓 (1 − 𝑓) − 𝑘12 𝑓
𝑑𝑡
Equation 2: Original fibroblast differential equation

7

fibroblast differential equation shown in Equation 2. The original MMP-1 and TIMP-1 data
was divided by the total number of proteins collected from the wound site. Then, the MMP1 and TIMP-1 data was rescaled for the Krishna et al. paper by dividing the MMP-1 and
TIMP-1 concentrations by the median initial concentration of TIMP-1 for good healers or
poor healers, depending upon which group was being modeled. Now through the rescaling
with the individual patient data, the MMP-1 and TIMP-1 concentration data is divided by
the average initial concentration of TIMP-1 for all patients. The next change to the original
model rescales the initial condition of the ECM data. In the Krishna et al. paper, the ECM
data was rescaled such that 0 represented the initial wound size and 1 represented a fully
closed and healed wound. When the individual patient data was acquired, it was found that
some patient’s wound areas increased from the initial measurement before the woundclosing process occurred. To avoid negative ECM levels, the ECM data was rescaled such
that the ceiling function of the largest wound area became 0, such that
𝑐𝑒𝑖𝑙𝑖𝑛𝑔(𝑙𝑎𝑟𝑔𝑒𝑠𝑡 𝑤𝑜𝑢𝑛𝑑 𝑎𝑟𝑒𝑎) →

𝑟𝑒𝑠𝑐𝑎𝑙𝑒𝑑

0. This method allowed for the various ECM

initial points of the individual patients to be graphed showing the variation in initial wound
area from patient to patient. Patients with ECM levels reaching 1 by the end of the 12 weeks
are still categorized as having closed wounds.
The third main difference between the original model and the updated model is
scaling 𝑘12 out of the equation due to structural identifiability issues. Structural
identifiability analyzes which parameters can be uniquely determined with an idealized,
noiseless data set (Eisenberg and Hayashi, 2014). The four differential equations could not
be solved for 13 unique parameters, 𝑘1 through 𝑘12 and 𝑓𝑖 ; the least informative parameter
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needed to be eliminated. After individual data was examined, it was determined that a key
factor in the individual wound healing process was the initial concentration of fibroblast
cells. To acknowledge this variation in the model, 𝑓 was defined as 𝑓̃ + 𝑓𝑖 . This change
also allows the carrying capacity of the

𝑑𝑓̃
𝑑𝑡

function to vary from patient to patient, such

that each individual’s carrying capacity is equal to 1 − 𝑓𝑖 . After these three rescalings were
performed, the new model shown in Equation 1 was obtained.

9

METHODS
Nonlinear Mixed Effects Modeling
This paper utilizes nonlinear mixed effects modeling to estimate parameters and
examine variation in the data. Mixed effects modeling is a technique that is well suited for
sparse data and is characterized as containing fixed effects and random effects. Fixed
effects are population parameters that are assumed to remain constant each time data is
collected. Random effects, contrastingly, are sample-dependent variables that vary from
patient to patient. The combination of fixed and random effects is such that

𝑘𝑖,𝑗 = 𝑒 (𝛽𝑖 +𝜙𝑖,𝑗) , i=1,…,12 , j=1,…,13
Equation 3: parameter estimate with fixed and random effects
where ki,j is the estimated value for the ith parameter for the jth patient, βi is the fixed effect
for the ith parameter for all patients, and 𝜙𝑖,𝑗 is the random effect for the ith parameter for
the jth patient. The exponential equation was chosen to ensure that the parameter values
will remain positive for all estimations.
Mixed effects modeling is particularly well suited for situations with sparse data
because this technique uses population trends in the data to inform individual curve fits.
This idea fits not only this model but many others since “the notion that individuals’
responses all follow a similar functional form with parameters that vary among individuals
seems to be appropriate in many situations” (Lindstrom and Bates, 1990). Mixed effects
modeling is attractive because of its ability to map high levels of variation within a model,
including splitting variation into within- and between-individual components. This
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technique is used frequently in the life sciences, specifically in pharmacokinetics, an
industry plagued with sparse data due to the difficulty of establishing medical trials.

Stochastic Approximation Expectation Maximization algorithm
A new development in mixed effects modeling incorporates the stochastic
approximation expectation maximization (SAEM) algorithm which has “proven very
efficient, quickly converging to the maximum likelihood estimators and performing better
than linearization-based algorithms” (Comets et al., 2017). A common issue found with
linearization-based algorithms is the increase in type I errors of likelihood tests that often
result due to the lack of knowledge of the transition probability density. To combat this
issue, SAEM algorithm codes have various ways of approximating the transition density.
This paper specifically uses Markov Chain Monte Carlo (MCMC) algorithms to
approximate the transition probability. The traditional method for mixed effects modeling
involves solving for the expected value of the loglikelihood function and then maximizing
that function for each iteration. The SAEM algorithm proposes a process that eliminates
the requirement of solving for the expected value of the loglikelihood function by
approximating this function through stochastic approximation of the logliklihood function
informed by MCMC estimates of the transition probability density. This approximated
expected value of the loglikelihood function is then maximized and the estimate for the
parameter is updated. A generic example of this process, as explained by Marc Lavielle
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and his collaborators in their 2010 presentation SAEM algorithm: a powerful stochastic
algorithm for population pharmacology modeling, is displayed below.
Let πθ be the transition probability of an ergodic markov chain with the
limiting distribution 𝑝ψ|𝑌 (∙ |𝑦; 𝜃). Steps one through three are performed
for each iteration k.
Step 1 – simulation: draw 𝜓 (𝑘) according to the transition probability
π𝜃𝑘−1 (𝜓 (𝑘−1) , ∙ ).
Step 2 – stochastic approximation:
𝑄𝑘 (𝜃) = 𝑄𝑘−1 (𝜃) + 𝛾𝑘 [log 𝑝(𝑦, 𝜓 (𝑘) ; 𝜃) − 𝑄𝑘−1 (𝜃)]
where 𝛾𝑘 is a decreasing sequence: ∑ 𝛾𝑘 = +∞ , ∑(𝛾𝑘 )2 < +∞
Step 3 – maximization:
𝜃𝑘 = 𝐴𝑟𝑔𝑚𝑎𝑥 𝑄𝑘 (𝜃)
Equation 4: Lavielle’s description of SAEM algorithm
where 𝜓 is a vector of random effect estimates, θ is a vector of estimated population
parameters, 𝑝(𝑦; 𝜃) = ∏𝑁
𝑖=1 𝑝(𝑦𝑖 ; 𝜃) is the likelihood function, and n is the number of
patients (Lavielle, et al., 2010). The simulation step generates simulated values of the
random effects given the current parameter estimates according to the transition probability
function and the posterior density. Then, the stochastic approximation “update[s] the
expected value of the loglikelihood function by taking its value from the previous step, and
moving part way toward the average value of the logliklihood calculated from the
simulated random effects” (MathWorks, 2017). The last step in the process, the
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maximization step, chooses the parameter estimates for the next iteration based on values
that maximize the 𝑄𝑘 (𝜃) function.

MATLAB’s nlmefitsa function
This paper uses the MATLAB function nlmefitsa, nonlinear mixed effects fit of the
data using the stochastic algorithm. This built-in function requires inputs of an n-by-h
matrix of n observations on h predictor variables, an n-by-1 vector of responses, a group
variable indicating from which patient the observation was taken, and a model function.
For this model, we also utilize a group-specific predictor variable matrix to assign patient
specific initial values to be used in the ordinary differential equation (ODE) solver. The
nlmefitsa function starts the process with user-selected initial guesses (Φ0) of the fixed
effects for the estimated parameters. For this paper, the original Φ0 guesses were taken
from average, curve-fitted values for the estimated parameters provided through work
completed by other members of the research group using the process described in the
Krishna et al. 2015 paper applied to individual patient values rather than average values.
After passing the Φ0 values through to the model function and solving the ODE system
with these parameter estimates, nlmefitsa records the differences between the solved-for
values and the recorded data for a specified state variable. Following this initial run,
nlmefitsa utilizes the SAEM algorithm to identify new, more accurate parameter values to
be used in the next iteration.
In the default programming of this function, each iteration utilizes six MCMC
algorithms split such that the first two MCMC iterations provide full multivariate updates,
the next two provide single coordinate updates, and the last two provide multiple
13

coordinate updates. As the mixed effects modeling iterations are being completed,
nlmefitsa displays run chains such as those shown in Figure 1. The β1 seen in Figure 1
represents the estimated fixed effects for one parameter for iterations 1 through 450. The
estimated fixed effect in the first iteration is simply the user-entered initial guess Φ0.
Figure 1: Example of run chains generateed by nlmefitsa

However by the 450th iteration, a new, more accurate fixed effects value has been
converged upon. The Ψ11 variable graphed in Figure 1 is the variance of the random effects
for the estimated parameter. Preferably, the variance would be large enough to allow the
parameter estimate to adequately explain the variation in the data but also small enough to
indicate an accurate fixed effect was chosen. If a covariance matrix was designed as an
input for nlmefitsa, covariances between two parameters’ random effects will also be
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shown in the output run chains. Figure 1 shows that an adequate parameter estimate has
been calculated by the function because the estimated values converge upon a single value.
This pattern often occurs at the end of the iteration cycle because the last third of the
iterations uses a reduced step-size in the algorithm when picking a new fixed value
estimate. The first third of the iterations combats poor initial estimates with a simulated
annealing algorithm, a probabilistic technique for approximating a global optimum of a
given function over a large space. In between the simulated annealing and reduced step
size iterations is the middle third of iterations which simply uses a full step-size process.
The other outputs of nlmefitsa are estimates of the fixed effects, variance and
covariance estimations for the random effects, the Akaike information criterion, the
Bayesian information criterion, the standard errors for the fixed effects estimates, the error
degrees of freedom, and the population, conditional, and individual weighted residuals.

Issues with nlmefitsa
While nlmefitsa is a useful function and readily available to implement through
MATLAB, there are certain drawbacks to this generic, built-in function. First, only local,
unconstrained optimizers are available to be selected as the optimiziation method,
fminsearch or fminunc. Since the model describes a biological process, there are certain
bounds in which a parameter value is biologically feasible. The limitation of a local
optimizer is that a constrained parameter space cannot be specified. Constrained optimizer
are available in MATLAB, such as fmincon. However their implementation is not
compatible with nlmefitsa at this time. Because of this issue, nlmefitsa may return
parameters values that are outside the realm of biological feasibility; this constrained space
15

has been set as [0,200] for parameters 𝑘1 though 𝑘11 and [0,1] for 𝑓𝑖 . The value of 200 has
been set due to a combination of biological reasoning and practical parameter value
estimations. Due to biological circumstances, it is unreasonable for k values to become
arbitrarily large. The specific value of 200 was selected through a Latin Hypercube
Sampling and Partial Rank Coorelation Coefficient process which showed that even when
the upper bound was increased to 500 or 1,000 the large majority of parameter estimates
occurred in the [0,200] range. Using 200 as an upper limit rather than 500 or 1,000 enables
the algorithms to sample a smaller space, saving computing time, while maintaining the
same confidence in the results. In attempt to resolve the local search function issue, a
minimum and a maximum function was inserted into the ODE system around the estimated
parameters such that max(0, min(𝑘1 ,200)) would replace 𝑘1 in the model function.
Essentially this function returns 200 if the parameter estimate computed by nlmefitsa is
greater than 200 and 0 if the estimate is less than 0. While this does not manipulate the
opimization function to generate more accurate estimates, it does allow us to take the
biologically feasible parameter space into account without modifying the complex
nlmefitsa built-in coding. However, issues do arise with parameter estimates outside of this
range since all numbers outside of the [0, 200] range enter either 0 or 200 into the ODE
system. This does not allow the mixed effects modeling system to witness the variations in
solutions.
The second issue with nlmefitsa is the limitation in recognizing only a single vector
of responses. This means that only one of the model’s four state variables can be fit at a
time. This issue also means that the other three state variables not being fit during the
estimation process must be fixed to some central value for all patients. Fixing such crucial
16

components of the model reduces the amount of information that can be extrapolated from
the results. The fixed state values were calculated as the average M, T, E, and 𝑓̃ values of
all patients over all time points. There was no modification available for the built-in
nlmefitsa function found that would provide the opportunity to fit for multiple response
variables at the same time.
SimBiology® Toolbox for MATLAB
A solution found for the one state variable limitation in nlmefitsa was the nonlinear
mixed effects modeling option in the SimBiology® Toolbox addition available for
MATLAB. SimBiology® “provides an app and programmatic tools to model, simulate, and
analyze dynamic systems, focusing on pharmacokinetic/pharmacodynamics (PK/PD) and
systems biology applications” (MathWorks, 2017). Since SimBiology® is specifically
designed to handle biological systems, this process offers more promising and accurate
results for the data fitting. SimBiology® also handles complex systems, necessary when
describing biological systems, more efficiently than nlmefitsa through built-in simulation
accelerators, ODE solvers, and stochastic algorithms. The nonlinear mixed effects
modeling function in SimBiology® offers a better suited system to fit the model as well as
the ability to fit multiple state variables at the same time. In addition, SimBiology® offers
a simplified, user-friendly interface which allows for easy changes and adjustments to the
model. This system uses the same nonlinear mixed effects modeling process described
above with the addition of a modification that enables rapid simulation such that each
iteration of the mixed effects modeling process proceeds quickly. Because of this addition,
the SimBiology®, even when fitting for all four state variables, delivers results in an eighth
17

of the time that the nlmefitsa function does. Because of the significant time difference and
more robust results, SimBiology® results will be focused on more heavily in this paper than
the results achieved through nlmefitsa.
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RESULTS
Preliminary nlmefitsa Results
Due to the time expensive results from nlmefitsa, only three fits have been included
in this paper. While there may be some inconsistencies regarding which and how many
parameters were estimated, the time cost of rerunning these simulations would take away
from more informative results. From searching the latest articles, it was found that
nonlinear mixed effects modeling, specifically using MATLAB’s nlmefitsa, is an
underutilized tool for ODE systems with multiple response variables. Because of this lack
of information, developing the nlmefitsa code was challenging. Therefore, the simplest
equation in the system,

𝑑𝑓̃
𝑑𝑡

, was fitted first. Figure 2 is the fit obtained for the 𝑓̃ variable

when all parameters were fixed except for 𝑘11 . Even 𝑓𝑖 was fixed to previously curve fitted
values for each patient. Each color represents a different patient according to the given key.
The points are simulated 𝑓̃ data using previously curve fitted 𝑘11 and 𝑓𝑖 values substituted
into the 𝑓̃(𝑡) equation and then numerically solved at the corresponding time points. Noise
was also added to the simulated data using a Gaussian curve with a mean of 0 and a variance
of 0.1. The corresponding colored lines are the curve fits for individual patients. The black
line represents a population fit which is the solution for the system when no random effects
are added to the equation, such that 𝑘11 = 𝑒 (𝛽11 ). This is a fit of Equation 5 where
̅̅̅̅̅̅̅̅̅̅̅̅̅̅̅ represents a parameter that has been fixed to an average of the curve fitted
𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟
patient data, 𝛽11is the fixed effects of 𝑘11 , and 𝜙11,𝑗 is the random effect for 𝑘11 for patient
𝑗. Because eleven of the twelve parameters and three of the four state variables were fixed,
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the parameter estimate and state variable fit returned from this run leaves much of the
variation of the data unexplained.

̅̅̅1 𝑀
̅𝑖 )
̅ 3 (𝑓̃ + 𝑓
𝑑𝑀 𝑘
̅̅̅3 𝑀
̅̅̅4 𝑀
̅ −𝑘
̅ 𝑇̅
=
−𝑘
3
3
𝑑𝑡
̅̅̅
̅
𝑘3 + 𝑀
̅̅̅5 𝑇̅ 3 (𝑓̃ + 𝑓
̅𝑖 )𝑀
̅
𝑑𝑇 𝑘
̅̅̅7 𝑇̅ − 𝑘
̅̅̅4 𝑀
̅ 𝑇̅
=
−𝑘
𝑑𝑡
̅̅̅6 3 + 𝑇̅ 3
𝑘
𝑑𝐸
̅̅̅8 (𝑓̃ + 𝑓
̅𝑖 )(1 − 𝐸̅ ) − 𝑘
̅̅̅9 𝑀
̅ 𝐸̅ − ̅̅̅̅
=𝑘
𝑘10 𝐸̅
𝑑𝑡
𝑑𝑓̃
̅𝑖 )[1 − (𝑓̃ + 𝑓
̅𝑖 )]
= (𝑒 (𝛽11 +𝜙11,𝑗) )(𝑓̃ + 𝑓
𝑑𝑡

Equation 5: Fixed equations to fit for 𝑓̃ and estimate 𝑘11

Patient

𝜙11

𝑒 𝜙11

𝑘11 =𝑒 (𝛽11 +𝜙11,𝑗 ) =

𝑒 (𝛽11 ) × 𝑒 (𝜙11 )

Previously
curvefitted

1

0.0829

1.0864

8.0420

5.2866

2

6.2337×10-4

1.0006

7.4070

81.4774

3

-0.0023

0.9977

7.3850

49.2129

4

7.1706×10-5

1.0001

7.4029

10.1484

5

0.0757

1.0787

7.9847

13.5138

6

-1.8095

0.1637

1.2121

10.9497

7

-2.5644

0.0770

0.5698

0.6609

8

-2.9677

0.0514

0.3806

0.2660

9

3.5590×10-4

1.0004

7.4050

37.7009

11

-2.7371

0.0648

0.4794

0.5006

12

8.7074×10-4

1.0009

7.4088

74.8162

14

-0.9372

0.3917

2.8997

5.8088

15

0.1501

1.1619

8.6011

49.5219

Table 1: Random effect estimates for 𝑘11 from the 𝑓̃ nlmefitsa run
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The fixed effect of 𝑘11 , 𝑒 (𝛽11 ) was found to be 7.4024 through this run of nlmefitsa.
The random effects and 𝑘11 estimates for each patient can be found in Table 1. The 𝑘11
estimates for patients 7, 8, and 11 are very close to previously curve fitted values. Due to
the other fixed state variables, the 𝑘11 estimates were prevented from reaching large
enough values to match previous curve fitted values for the rest of the patients. The run
chains for this fit were used as the example run chains in Figure 1 above. This figure also
shows the variance of the random effects, ϕ11 , which was calculated as 7.2437. This is a
fairly large variance considering the fixed effect is 7.4024. The root mean squared error
of this nonlinear fit is 0.0654, suggesting that the fit is relatively helpful for predictions of
Figure 2: Fit for 𝑓̃ using nlmefitsa
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𝑓̃ because the mean squared error is close to 0. Another way to evaluate the fit is graphical
evidence shown in Figure 2. The individual curve fits generally match the data trend of the
individual simulated data. The population curve, the black line, shows an initial population
value around 0.45. The fact that the population curve follows the trend of the majority of
individuals indicates that the fit ran properly and that the population curve is an adequate
representation of the population. It is important to note the three patients whose
concentrations of fibroblast cells do not increase as quickly as the others; those patients are
7, 8, and 11. The fibroblasts may have encountered obstacles when migrating to these
patients’ wound site due to a slow healing response, perhaps due to high levels of MMPs
or low levels of TIMPs. The average residual for data points for patient 7 is 0.0134. The
average residual for patient 8 is 0.0061. It is 0.0047 for patient 11. These rather low average
residuals for patient 7, 8, and 11 suggest that the model decently captures the variations in
the data points for these three patients. Since the model offers low residuals even for the
three patients varying the most for the general population trend, it can be inferred that
decent fits can be obtained for most patients.
The next run accomplished with nlmefitsa was the fit for 𝑀, MMP-1. For this run,
all parameters, except for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 , were fixed to the curve fitted values for
patient 7. The estimated fixed effects can be found in Table 2. Since the minimummaximum function has been put in place, the fixed values for 𝑘7 and 𝑘8 which are clearly
Parameter
Fixed effect

𝑘3

1.991×10

-33

𝑘4
0.0024

𝑘6
3.548×10-5

𝑘7
2.902×104

Table 2: Fixed effects for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 from the 𝑀 nlmefitsa run
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𝑘8
7.511×105

above the 200 threshold are actually entered into the ODE as 200. Therefore, the fixed
effects for 𝑘7 and 𝑘8 are actually 200. The fixed effect for 𝑘3 is extremely close to 0. This
is concerning as it means that the population trend has no decay rate for the matrix
metalloproteinases, represented by 𝑘3 in the model. However, this does follow the
Lobmann et al. study which shows that the levels of MMP-1 in diabetic chronic wounds is
65-fold larger than the levels in acute wounds. Since the death rate is very small, matrix
metalloproteinases stay longer at the wound site and break apart more sections of the ECM,
preventing the wound from healing. The decay rate of the TIMP-1 is 𝑘7 . Thus a large value
for 𝑘7 also follows Lobmann et al.’s findings that the concentration of TIMP-1 is decreased
twofold in diabetic chronic wounds compared to acute wounds. A large 𝑘8 value indicates
a large ECM production rate and promotes wound healing. This value may represent an
overproduction of ECM to combat the increased concentrations of MMP proteins.
The estimated parameter values for each patient are shown in Table 3. Beside each
estimate from the nlmefitsa code is the previously curve fitted values to indicate whether
or not the estimates are similar. The nlmefitsa values do not seem to capture the variability
of the model. Almost none of the nlmefitsa values are of the same order of magnitude as
the previously curve fitted values. This is most likely because the fminsearch function has
allowed the system to converge to values that are not in the biologically feasible range. The
implementation of a constrained optimizer would deliver better results. The run chains for
this nlmefitsa run are shown in Appendix 2.1.
Another reason that the parameter estimates may be different from the previously
curve fitted values is that one patient’s curve fit skews the population trend and therefore

23

1

1.99×10-33

Curve fitted
𝑘3
15.3514

2

2.18×10-33

0.2758

1.8526

1.0186

3.56×10-5

3.2047

3

1.52×10-33

2.5809

0.3104

0.8865

3.57×10-5

0.6041

4

2.10×10-33

1.9271

3.3484

11.1258

3.92×10-5

44.7713

5

2.35×10-33

0.0095

0.0014

0.4050

3.59×10-5

2.1726

6

1.99×10-33

0.2118

0.0023

0.0932

3.55×10-5

0.3929

7

1.95×10-33

0.0020

0.0005

0.0036

3.57×10-5

4.6668

8

1.99×10-33

8.89×10-6

0.0022

1.14×10-5

3.55×10-5

33.6742

9

1.82×10-33

0.0028

0.0011

0.0360

3.45×10-5

0.9942

11

1.99×10-33

36.4

0.0022

0.0289

3.55×10-5

2.1492

12

1.95×10-33

0.0530

0.1102

0.0681

3.55×10-5

2.2605

14

1.93×10-33

0.0147

0.0025

0.0840

3.53×10-5

1.0110

15

2.93×10-33

0.0039

0.0006

0.8940

3.65×10-5

0.1195

𝑘3

0.0021

Curve fitted
𝑘4
0.5337

3.55×10-5

Curve fitted
𝑘6
0.3520

𝑘4

2.90×104

Curve fitted
𝑘7
4.5641

7.51×107

Curve fitted
𝑘8
32.9586

2.74×104

0.1016

8.84×107

26.7042

2.91×104

5.4668

4.45×107

42.5586

3.51×104

7.9222

6.56×107

5.7413

2.95×104

0.1060

8.23×107

35.5018

2.90×104

2.8441

7.50×107

36.6025

2.93×104

0.0672

1.04×106

68.9492

2.90×104

1.13×10-6

7.51×107

39.8318

3.11×104

11.3855

9.95×107

160.9344

2.90×10

4

0.0644

7.51×10

7

61.9300

2.91×104

0.0699

7.80×107

32.6444

2.93×104

0.8100

7.62×107

11.3146

2.96×104

0.0149

1.22×106

16.8799

𝑘7

𝑘8

𝑘6

Table 3: Individual patient estimates for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 from the 𝑀 nlmefitsa run
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the estimated fixed effects corresponding random effects. The concentration of MMP’s
should increase during the first few weeks of healing, but once the MMP proteins begin to
Figure 3: Fit for M using nlmefitsa

interact with the TIMP’s, the concentration should decrease as the wound heals. Patient 9’s
concentration of MMP’s steadily increases during the first four weeks and then healed
before week 8. Because of this, the only data available for patient 9 is at time points
[0,1,2,4]. The curve fit produced by nlmefitsa observed this increase and then interpreted
the remaining eight weeks, without data points, as a near exponential increase in MMP’s
shown in Figure 3. The parameter estimates for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 for patient 9 are more
similar to the previously fitted estimates, taking into consideration that the 𝑘7 and 𝑘8 values
were returned to the ODE solver as 200. The estimate for 𝑘4 for patient 9 was more similar
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to the previously fitted value than most of the patients’ estimates. The curve fit for patient
9 has skewed the population fit and led to poor parameter estimates. If this run were to be
reexamined, better results may occur if patient 9 is excluded from the data set.
The last fit run with the nlmefitsa algorithm was for state variable 𝑇 while
estimating for parameters 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 , as in the fit for 𝑀 above. The fixed effects
estimates for these parameters in Table 4 are very different than the estimates in the 𝑀 fit.
These estimates are within the [0, 200] range. However, these estimates are smaller than
Parameter
Fixed effect

𝑘3

1.8307

𝑘4
0.9764

𝑘6
2.1555

𝑘7
0.7864

𝑘8
1.7453

Table 4: Fixed effects for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 from the 𝑇 nlmefitsa run
the average of the curve fitted values for all patients which are 7.5167, 14.9013, 25.5439,
9.9722, and 53.7389 for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 , respectively. The cause of this may be that
too many of the parameters were fixed to accurately convey the variability in the data or
the fixed values were inadequate. The individual parameter estimates in Table 5 are very
tightly clustered with little variation from patient to patient. These values can be compared
to the previously curve fitted values displayed in Table 3. When compared to the previously
curve fitted values, 𝑘8 stands out as the most different. While the previous estimates for
this parameter boast a range of 155.1931, the nlmefitsa estimates have a range of 0.021.
Clearly, the nlmefitsa estimates are missing key variation in the data. The root mean
squared error of this fit is 0.5018 which indicates that this is not a particularly helpful model
to predict 𝑇 values, since the mean squared error is not significantly close to 0.
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𝑘3
1
2
3
4
5
6
7
8
9
11
12
14
15

1.8899
1.8621
1.2243
2.1919
1.5540
1.6715
1.7806
1.8448
1.4990
1.8290
2.3396
1.9187
1.2707

𝑘4
0.9657
0.9447
0.8433
1.0476
1.0222
1.0051
0.9845
0.9738
0.9337
0.9767
0.8957
0.9622
0.8564

𝑘6
2.1553
1.6287
0.6289
2.0664
2.2157
2.1616
2.1668
2.1554
0.5824
2.1554
1.8660
2.1419
0.4341

𝑘7
0.7767
0.7566
0.6956
0.7657
0.8494
0.8166
0.7965
0.7841
0.8873
0.7867
0.6991
0.7703
0.7455

𝑘8
1.7453
1.7451
1.7491
1.7420
1.7454
1.7453
1.7453
1.7453
1.7613
1.7453
1.7453
1.7453
1.7403

Table 5: Individual patient estimates for 𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , and 𝑘8 from the 𝑇 nlmefitsa run
The estimated fits for 𝑇 from this run of nlmefitsa in Figure 5 seem to be stuck in
an area bounded by 0.2 and 1.5 concentration of TIMPs, even though there are data points
outside of this band. Most patients tend to follow the biological pattern of increased
concentrations of TIMP’s that then are reduced by their interaction with the MMP’s and
then reach a steady state. The three patients that do not follow this trend are patients 1, 8,
and 11. These patients have constant concentrations of TIMP curve fits. This is particularly
concerning because the scaled data for these three patients show the same observed trend
as in the rest of the patients. The fixed values, local search optimizer, and working in a 5dimensional system, with the other seven parameters fixed, has created issues with using
nlmefitsa and curve fits in general. Using the SimBiology® toolbox will allow for multiple
state variables to be estimated during a single run but it still suffers from the three above
listed problems that plague this technique for this model. However, the benefit of being
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able to take all four data sets, for M, T, E, and ̃f, will decrease the parameter identifiability
issues since the program will then be working with a more informed model.
Figure 4: Fit for T using nlmefitsa

Preliminary SimBiology® Results
A couple SimBiology® fit results have been included to show how this toolbox fits
all four state variables for all patients. The first successful run using SimBiology® was
similar to the first nlmefitsa run. All parameters were fixed except for 𝑘11 and only 𝑓̃ was
fitted, the other state variables were fixed to the average value from the data. The estimated
fixed effect for 𝑘11 is 15.8115. This value is more than double the fixed effect estimated
from the nlmefitsa run using the same fixed parameter values. The individual patient
estimates are all equal to the fixed effect estimate. Because of this, the 𝑓̃ curve fits are the
same for all patients as seen in Figure 5. All curve fits are basically just a straight line at 1.
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SimBiology® currently does not have an option to supply different initial conditions for
each patient without adding each initial condition as a new parameter to be estimated. This
may be one of the reasons that all the curve fits are the same, as the model is using the same
Figure 5: Fit for 𝑓̃ using SimBiology®

initial condition for all patients. This fit returned a root mean square value of 0.5133
indicating that this fit is significantly less predictive than the nlmefitsa run for the same
parameter-state variable combination. The variance of 𝑘11 was found to be 2.2941. With a
larger variance and a less predictive fit, nlmefitsa seems to have outperformed
SimBiology® on this fit of the model. Additional graphs generated from this run can be
found in Appendix 4.
The next fit run through SimBiology® estimates 𝑘1 , 𝑘2 , and 𝑘8 while fitting for M,
T, and E state variables. Since these three parameters were determined to be the most
informative subset of the parameter for patient 1, patient 1 previously curve fitted values
were used for the other parameters. The fixed effect estimates for 𝑘1 , 𝑘2 , and 𝑘8 are listed
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in Table 6. However, the individual parameter estimates do not vary enough to explain the
variation in the data. The variances for 𝑘1 , 𝑘2 , and 𝑘8 were estimated to be 0.0059, 0.1999,
and 0.0065, respectively.
Parameter
Fixed effect

𝑘1

𝑘2
0.0155

6.8159

𝑘8
5.0916

Table 6: Fixed effects for 𝑘1 , 𝑘2 , and 𝑘8 from the 𝑀, 𝑇, 𝐸 SimBiology® run

Figure 6: Fit for 𝑀, 𝑇, 𝐸 using SimBiology®

What this run lacks in predictive capabilities, it makes up for in the ability to view
estimates for three of the state variables at the same time. While the individual fits for the
state variables are not significantly predictive curve fits, this was the first successful run
that allowed multiple state variables to be fit, as shown in Figure 6. The blue data points
and curve fits correspond to state variable M, red for T, and yellow for E. The curve fits for
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each individual are extremely similar, a reflection of all patients having the same parameter
estimates.
The last SimBiology® run analyzed in this paper offers a more varied fit of all four
state variables and estimates for k 3 , k 4 , k 6 , k 7 , k 8 and 𝑓𝑖 . The fixed effects are listed in
Table 7. Once again, since the minimum-maximum function has been executed, the fixed
effect estimate for 𝑘6 is entered into the ODE system as 200. The random effects for all
Parameter
Fixed effect

𝑘3

5.15×10

-5

𝑘4
0.0019

𝑘6
𝑘7
𝑘8
𝑓𝑖
3
-4 15.1373 0.0321
4.07×10 3.34×10

Table 7: Fixed effects for𝑘3 , 𝑘4 , 𝑘6 , 𝑘7 , 𝑘8 and 𝑓𝑖 from the 𝑀, 𝑇, 𝐸, 𝑓̃ SimBiology® run
patients for 𝑘3 , 𝑘4 , 𝑘6 and 𝑘7 are very similar, resulting in basically equal parameter
estimates for each patient. However, the estimates for 𝑘8 and 𝑓𝑖 reflect the data’s variability
Patient
1

𝑘8
16.3774

𝑓𝑖
0.0261

2

8.4179

0.1461

3

19.2386

0.0169

found

4

17.2850

0.0225

covariance matrix was calculated for

5

21.8686

0.0120

6

17.6867

0.0212

7

6.5000

0.3592

8

4.4883

0.9614

value for this fit of the model is

9

16.3581

0.0261

0.4600, meaning that this is not the

11

3.9870

1.0000

12

18.2929

0.0193

14

21.8635

0.0273

however it is the most predictive

15

16.1096

0.0321

model for the most number of state

more accurately. The individual
patient estimates for 𝑘8 and 𝑓𝑖 can be
in

Table

8.

The

entire

this run which can be found in
Appendix 6.1. The root mean square

most predictive included in this paper

Table 8: Individual patient estimates for 𝑘8 and
variables. The individual curve fits
𝑓𝑖 from the 𝑀, 𝑇, 𝐸, 𝑓̃ SimBiology® run
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are shown in Figure 7. In the graphs, blue data points and lines represent M, red is for T,
yellow is E, and purple is 𝑓̃.
Figure 6: Fit for 𝑀, 𝑇, 𝐸, 𝑓̃ using SimBiology®
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CONCLUSIONS AND FUTURE WORK

While nlmefitsa offers more versatility by way of modifying and adapting the code
in the regular MATLAB interface, it also comes with significant limitations such as only
fitting for one state variable and only using local search algorithms. On the other hand,
SimBiology® offers an easy-to-navigate user interface while also allowing for multiple
state variables to be fit. SimBiology® also boasts a faster simulation time due to the
modifications built into the PK/PD models for rapid simulation. However, SimBiology® is
still simply an extension of the MATLAB nlmefitsa function and suffers from the lack of
a constrained optimizer.
After trying both of these methods of implementing mixed effects modeling, it has
been decided that SimBiology® offers more opportunities for a reasonable convergence to
be obtained and more advanced fits to be generated. However, there are a few issues that
should be addressed in later simulations and fit of this model. One of this issues is the
crucial initial guesses for estimated parameters and fixed values for the non-estimated
parameters. Incorrect fixed values may encourage the ODE system to converge to
unreasonable estimates. Dozens of runs should be simulated using a variety of previously
curve fitted data and previously calculated estimates. The fixed effect estimates from these
runs should be compared and inform the choosing of the most appropriate fixed values for
this model.
Another effort in furthering this work would be to review other programming
software that may be better equipped for dealing with such complex nonlinear mixed
effects modeling. There built-in functions for nonlinear mixed effect modeling in both R
33

and SAS that should be examined. However, there is a very promising program MONLIX
that was specifically designed for nonlinear mixed effects modeling with the SAEM
algorithm addition. MONOLIX was designed and still involves a multi-disciplinary group
of academic statisticians from several universities in Paris, researchers in the pharmacology
industry, researchers in the agronomy, animal genetics, industry, and scientists in the
oncology department of the medical institute at the Lyon-Sud University in Villeurbanne,
France (Mentré et al., 2008). MONOLIX may provide the robust computing ability and the
intricate fitting algorithms this technique needs.
In the future, there may be adaptations or additions that could be made to the model
to improve the predicitive and informative capacity. Since it has been found that a lack of
monocytes or macrophages can cause serious delays in wound healing (Velnar et al., 2009),
it may be beneficial to collect data on these cells in future data collection as well as expand
the model. This may prove to be difficult since the blood monocytes transition into tissue
macrophages during the early part of the inflammatory phase of healing. The transition
may be challenging to capture in both a modeling and data collection sense. In general,
additional data collection would encourage more accurate results from nlmefitsa. A
temporary solution to this would be to include all sixteen patients in future runs of nonlinear
mixed effects modeling. In the paper only thirteen patients were included because these
were the patients with the most data points. Since nonlinear mixed effects modeling is
specifically designed to handle sparse data, the additional data points for any patients
should help inform results.
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APPENDEX
Appendix 1.1: Individual patient residual for nlmefitsa run for 𝑓̃

Appendix 1.2: Conditional weighted patient residual for nlmefitsa run for 𝑓̃
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Appendix 2.1: Run chains for the nlmefitsa run for M
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Appendix 2.2: Individual patient residuals from the nlmefitsa run for M

Appendix 2.3: Conditional weighted residuals from the nlmefitsa run for M
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Appendix 3.1: Individual patient residuals from the nlmefitsa run for T

Appendix 3.2: Conditional weighted residuals from the nlmefitsa run for T
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Appendix 4.1: Observation versus prediction from the SimBiology® run for 𝑓̃

Appendix 4.2: Box plot of random effects from the SimBiology® run for 𝑓̃
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Appendix 4.3: Weighted and individual residuals from the SimBiology® run for 𝑓̃

Appendix 5.1: Observation versus prediction for the SimBiology® run for M, T, and E

Top left: Observation versus
prediction graph for M
Top right: Observation versus
prediction graph for T
Bottom left: Observation versus
prediction graph for E
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Appendix 5.2: Random effects box plots for the SimBiology® run for M, T, and E
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Appendix 5.3: Residual distribution plots for the SimBiology® run for M, T, and E

CWRES: Conditional Weighted Residuals
IWRES: Individual Weighted Residuals
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Appendix 6.1: Covariance of random effects for the SimBiology® run for M, T, E, and 𝑓̃
𝑘3

𝑘4

𝑘6

𝑘7

𝑘8

𝑓𝑖

𝑘3

1.1431

0.9028

0.0217

0.8422

-0.9865

2.4835

𝑘4

0.9028

0.7991

0.0390

0.8112

-0.8883

2.3676

𝑘6

0.0217

0.0390

0.0222

-0.0245

-0.0194

0.0711

𝑘7

0.8422

0.8112

-0.0245

1.3038

-1.0520

2.8991

𝑘8

-0.9865

-0.8883

-0.0194

-1.0520

1.0369

-2.7931

𝑓𝑖

2.4835

2.3676

0.0711

2.8991

-2.7931

7.7208

Appendix 6.2: Population fit for the SimBiology® run for M, T, E, and 𝑓̃
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Appendix 6.3: Observation versus prediction for the SimBiology® run for M, T, E, and 𝑓̃

Top left: Observation versus prediction for state variable M
Top right: Observation versus prediction for state variable T
Bottom left: Observation versus prediction for state variable E
Bottom right: Observation versus prediction for state variable 𝑓̃
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Appendix 6.4: Box plot of random effects for the SimBiology® run for M, T, E, and 𝑓̃
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Appendix 6.5: Residual distributions for the SimBiology® run for M, T, E, and 𝑓̃

CWRES: Conditional Weighted Residuals
IWRES: Individual Weighted Residuals
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